GPM #:  
Keyword:  


# GPM # proteins Description
1. GPM45100100786
metadata 
peptide 
model 
group 
aaa 
gel
mh
go
2379
  1. BRENDA cell culture: none
  2. BRENDA tissue: BTO:0000759  liver
  3. CELL cell type: none
  4. GO subcellular: none
  5. email: christine.wegler@farmaci.uu.se
  6. institution: Uppsala University, et al.
  7. name: Christine Wegler,et al.
  8. project: Influence of Proteome Profiles and Intracellular Drug Exposure on Differences in CYP Activity in Donor-Matched Human Liver Microsomes and Hepatocytes
  9. project comment: Data from ProteomeXchange, PXD014131. File: Christine_TPA_180223_LysC_H1.mzml. Published as part of Mol Pharm. 2021 Mar 19 (PubMed ). From ProteomeXchange: LC-MS/MS-based label-free proteomics of human liver homogenate, human liver microsomes, and human hepatocytes from 15 matched donors used to compare and understand differences in two major in vitro systems used for drug metabolism studies
2. GPM45100100787
metadata 
peptide 
model 
group 
aaa 
gel
mh
go
2518
  1. BRENDA cell culture: none
  2. BRENDA tissue: BTO:0000759  liver
  3. CELL cell type: none
  4. GO subcellular: none
  5. email: christine.wegler@farmaci.uu.se
  6. institution: Uppsala University, et al.
  7. name: Christine Wegler,et al.
  8. project: Influence of Proteome Profiles and Intracellular Drug Exposure on Differences in CYP Activity in Donor-Matched Human Liver Microsomes and Hepatocytes
  9. project comment: Data from ProteomeXchange, PXD014131. File: Christine_TPA_180223_LysC_H11.mzml. Published as part of Mol Pharm. 2021 Mar 19 (PubMed ). From ProteomeXchange: LC-MS/MS-based label-free proteomics of human liver homogenate, human liver microsomes, and human hepatocytes from 15 matched donors used to compare and understand differences in two major in vitro systems used for drug metabolism studies
3. GPM45100100788
metadata 
peptide 
model 
group 
aaa 
gel
mh
go
2268
  1. BRENDA cell culture: none
  2. BRENDA tissue: BTO:0000759  liver
  3. CELL cell type: none
  4. GO subcellular: none
  5. email: christine.wegler@farmaci.uu.se
  6. institution: Uppsala University, et al.
  7. name: Christine Wegler,et al.
  8. project: Influence of Proteome Profiles and Intracellular Drug Exposure on Differences in CYP Activity in Donor-Matched Human Liver Microsomes and Hepatocytes
  9. project comment: Data from ProteomeXchange, PXD014131. File: Christine_TPA_180223_LysC_H12.mzml. Published as part of Mol Pharm. 2021 Mar 19 (PubMed ). From ProteomeXchange: LC-MS/MS-based label-free proteomics of human liver homogenate, human liver microsomes, and human hepatocytes from 15 matched donors used to compare and understand differences in two major in vitro systems used for drug metabolism studies
4. GPM45100100789
metadata 
peptide 
model 
group 
aaa 
gel
mh
go
2352
  1. BRENDA cell culture: none
  2. BRENDA tissue: BTO:0000759  liver
  3. CELL cell type: none
  4. GO subcellular: none
  5. email: christine.wegler@farmaci.uu.se
  6. institution: Uppsala University, et al.
  7. name: Christine Wegler,et al.
  8. project: Influence of Proteome Profiles and Intracellular Drug Exposure on Differences in CYP Activity in Donor-Matched Human Liver Microsomes and Hepatocytes
  9. project comment: Data from ProteomeXchange, PXD014131. File: Christine_TPA_180223_LysC_H13.mzml. Published as part of Mol Pharm. 2021 Mar 19 (PubMed ). From ProteomeXchange: LC-MS/MS-based label-free proteomics of human liver homogenate, human liver microsomes, and human hepatocytes from 15 matched donors used to compare and understand differences in two major in vitro systems used for drug metabolism studies
5. GPM45100100790
metadata 
peptide 
model 
group 
aaa 
gel
mh
go
2123
  1. BRENDA cell culture: none
  2. BRENDA tissue: BTO:0000759  liver
  3. CELL cell type: none
  4. GO subcellular: none
  5. email: christine.wegler@farmaci.uu.se
  6. institution: Uppsala University, et al.
  7. name: Christine Wegler,et al.
  8. project: Influence of Proteome Profiles and Intracellular Drug Exposure on Differences in CYP Activity in Donor-Matched Human Liver Microsomes and Hepatocytes
  9. project comment: Data from ProteomeXchange, PXD014131. File: Christine_TPA_180223_LysC_H14.mzml. Published as part of Mol Pharm. 2021 Mar 19 (PubMed ). From ProteomeXchange: LC-MS/MS-based label-free proteomics of human liver homogenate, human liver microsomes, and human hepatocytes from 15 matched donors used to compare and understand differences in two major in vitro systems used for drug metabolism studies
6. GPM45100100791
metadata 
peptide 
model 
group 
aaa 
gel
mh
go
2355
  1. BRENDA cell culture: none
  2. BRENDA tissue: BTO:0000759  liver
  3. CELL cell type: none
  4. GO subcellular: none
  5. email: christine.wegler@farmaci.uu.se
  6. institution: Uppsala University, et al.
  7. name: Christine Wegler,et al.
  8. project: Influence of Proteome Profiles and Intracellular Drug Exposure on Differences in CYP Activity in Donor-Matched Human Liver Microsomes and Hepatocytes
  9. project comment: Data from ProteomeXchange, PXD014131. File: Christine_TPA_180223_LysC_H16.mzml. Published as part of Mol Pharm. 2021 Mar 19 (PubMed ). From ProteomeXchange: LC-MS/MS-based label-free proteomics of human liver homogenate, human liver microsomes, and human hepatocytes from 15 matched donors used to compare and understand differences in two major in vitro systems used for drug metabolism studies
7. GPM45100100792
metadata 
peptide 
model 
group 
aaa 
gel
mh
go
2210
  1. BRENDA cell culture: none
  2. BRENDA tissue: BTO:0000759  liver
  3. CELL cell type: none
  4. GO subcellular: none
  5. email: christine.wegler@farmaci.uu.se
  6. institution: Uppsala University, et al.
  7. name: Christine Wegler,et al.
  8. project: Influence of Proteome Profiles and Intracellular Drug Exposure on Differences in CYP Activity in Donor-Matched Human Liver Microsomes and Hepatocytes
  9. project comment: Data from ProteomeXchange, PXD014131. File: Christine_TPA_180223_LysC_H17.mzml. Published as part of Mol Pharm. 2021 Mar 19 (PubMed ). From ProteomeXchange: LC-MS/MS-based label-free proteomics of human liver homogenate, human liver microsomes, and human hepatocytes from 15 matched donors used to compare and understand differences in two major in vitro systems used for drug metabolism studies
8. GPM45100100793
metadata 
peptide 
model 
group 
aaa 
gel
mh
go
2337
  1. BRENDA cell culture: none
  2. BRENDA tissue: BTO:0000759  liver
  3. CELL cell type: none
  4. GO subcellular: none
  5. email: christine.wegler@farmaci.uu.se
  6. institution: Uppsala University, et al.
  7. name: Christine Wegler,et al.
  8. project: Influence of Proteome Profiles and Intracellular Drug Exposure on Differences in CYP Activity in Donor-Matched Human Liver Microsomes and Hepatocytes
  9. project comment: Data from ProteomeXchange, PXD014131. File: Christine_TPA_180223_LysC_H18.mzml. Published as part of Mol Pharm. 2021 Mar 19 (PubMed ). From ProteomeXchange: LC-MS/MS-based label-free proteomics of human liver homogenate, human liver microsomes, and human hepatocytes from 15 matched donors used to compare and understand differences in two major in vitro systems used for drug metabolism studies
9. GPM45100100794
metadata 
peptide 
model 
group 
aaa 
gel
mh
go
2181
  1. BRENDA cell culture: none
  2. BRENDA tissue: BTO:0000759  liver
  3. CELL cell type: none
  4. GO subcellular: none
  5. email: christine.wegler@farmaci.uu.se
  6. institution: Uppsala University, et al.
  7. name: Christine Wegler,et al.
  8. project: Influence of Proteome Profiles and Intracellular Drug Exposure on Differences in CYP Activity in Donor-Matched Human Liver Microsomes and Hepatocytes
  9. project comment: Data from ProteomeXchange, PXD014131. File: Christine_TPA_180223_LysC_H19.mzml. Published as part of Mol Pharm. 2021 Mar 19 (PubMed ). From ProteomeXchange: LC-MS/MS-based label-free proteomics of human liver homogenate, human liver microsomes, and human hepatocytes from 15 matched donors used to compare and understand differences in two major in vitro systems used for drug metabolism studies
10. GPM45100100795
metadata 
peptide 
model 
group 
aaa 
gel
mh
go
2238
  1. BRENDA cell culture: none
  2. BRENDA tissue: BTO:0000759  liver
  3. CELL cell type: none
  4. GO subcellular: none
  5. email: christine.wegler@farmaci.uu.se
  6. institution: Uppsala University, et al.
  7. name: Christine Wegler,et al.
  8. project: Influence of Proteome Profiles and Intracellular Drug Exposure on Differences in CYP Activity in Donor-Matched Human Liver Microsomes and Hepatocytes
  9. project comment: Data from ProteomeXchange, PXD014131. File: Christine_TPA_180223_LysC_H2.mzml. Published as part of Mol Pharm. 2021 Mar 19 (PubMed ). From ProteomeXchange: LC-MS/MS-based label-free proteomics of human liver homogenate, human liver microsomes, and human hepatocytes from 15 matched donors used to compare and understand differences in two major in vitro systems used for drug metabolism studies
11. GPM45100100796
metadata 
peptide 
model 
group 
aaa 
gel
mh
go
2121
  1. BRENDA cell culture: none
  2. BRENDA tissue: BTO:0000759  liver
  3. CELL cell type: none
  4. GO subcellular: none
  5. email: christine.wegler@farmaci.uu.se
  6. institution: Uppsala University, et al.
  7. name: Christine Wegler,et al.
  8. project: Influence of Proteome Profiles and Intracellular Drug Exposure on Differences in CYP Activity in Donor-Matched Human Liver Microsomes and Hepatocytes
  9. project comment: Data from ProteomeXchange, PXD014131. File: Christine_TPA_180223_LysC_H21.mzml. Published as part of Mol Pharm. 2021 Mar 19 (PubMed ). From ProteomeXchange: LC-MS/MS-based label-free proteomics of human liver homogenate, human liver microsomes, and human hepatocytes from 15 matched donors used to compare and understand differences in two major in vitro systems used for drug metabolism studies
12. GPM45100100797
metadata 
peptide 
model 
group 
aaa 
gel
mh
go
2095
  1. BRENDA cell culture: none
  2. BRENDA tissue: BTO:0000759  liver
  3. CELL cell type: none
  4. GO subcellular: none
  5. email: christine.wegler@farmaci.uu.se
  6. institution: Uppsala University, et al.
  7. name: Christine Wegler,et al.
  8. project: Influence of Proteome Profiles and Intracellular Drug Exposure on Differences in CYP Activity in Donor-Matched Human Liver Microsomes and Hepatocytes
  9. project comment: Data from ProteomeXchange, PXD014131. File: Christine_TPA_180223_LysC_H22.mzml. Published as part of Mol Pharm. 2021 Mar 19 (PubMed ). From ProteomeXchange: LC-MS/MS-based label-free proteomics of human liver homogenate, human liver microsomes, and human hepatocytes from 15 matched donors used to compare and understand differences in two major in vitro systems used for drug metabolism studies
13. GPM45100100798
metadata 
peptide 
model 
group 
aaa 
gel
mh
go
2253
  1. BRENDA cell culture: none
  2. BRENDA tissue: BTO:0000759  liver
  3. CELL cell type: none
  4. GO subcellular: none
  5. email: christine.wegler@farmaci.uu.se
  6. institution: Uppsala University, et al.
  7. name: Christine Wegler,et al.
  8. project: Influence of Proteome Profiles and Intracellular Drug Exposure on Differences in CYP Activity in Donor-Matched Human Liver Microsomes and Hepatocytes
  9. project comment: Data from ProteomeXchange, PXD014131. File: Christine_TPA_180223_LysC_H23.mzml. Published as part of Mol Pharm. 2021 Mar 19 (PubMed ). From ProteomeXchange: LC-MS/MS-based label-free proteomics of human liver homogenate, human liver microsomes, and human hepatocytes from 15 matched donors used to compare and understand differences in two major in vitro systems used for drug metabolism studies
14. GPM45100100799
metadata 
peptide 
model 
group 
aaa 
gel
mh
go
2276
  1. BRENDA cell culture: none
  2. BRENDA tissue: BTO:0000759  liver
  3. CELL cell type: none
  4. GO subcellular: none
  5. email: christine.wegler@farmaci.uu.se
  6. institution: Uppsala University, et al.
  7. name: Christine Wegler,et al.
  8. project: Influence of Proteome Profiles and Intracellular Drug Exposure on Differences in CYP Activity in Donor-Matched Human Liver Microsomes and Hepatocytes
  9. project comment: Data from ProteomeXchange, PXD014131. File: Christine_TPA_180223_LysC_H24.mzml. Published as part of Mol Pharm. 2021 Mar 19 (PubMed ). From ProteomeXchange: LC-MS/MS-based label-free proteomics of human liver homogenate, human liver microsomes, and human hepatocytes from 15 matched donors used to compare and understand differences in two major in vitro systems used for drug metabolism studies
15. GPM45100100800
metadata 
peptide 
model 
group 
aaa 
gel
mh
go
2167
  1. BRENDA cell culture: none
  2. BRENDA tissue: BTO:0000759  liver
  3. CELL cell type: none
  4. GO subcellular: none
  5. email: christine.wegler@farmaci.uu.se
  6. institution: Uppsala University, et al.
  7. name: Christine Wegler,et al.
  8. project: Influence of Proteome Profiles and Intracellular Drug Exposure on Differences in CYP Activity in Donor-Matched Human Liver Microsomes and Hepatocytes
  9. project comment: Data from ProteomeXchange, PXD014131. File: Christine_TPA_180223_LysC_H26.mzml. Published as part of Mol Pharm. 2021 Mar 19 (PubMed ). From ProteomeXchange: LC-MS/MS-based label-free proteomics of human liver homogenate, human liver microsomes, and human hepatocytes from 15 matched donors used to compare and understand differences in two major in vitro systems used for drug metabolism studies
16. GPM45100100801
metadata 
peptide 
model 
group 
aaa 
gel
mh
go
208
  1. BRENDA cell culture: none
  2. BRENDA tissue: BTO:0000759  liver
  3. CELL cell type: none
  4. GO subcellular: none
  5. email: christine.wegler@farmaci.uu.se
  6. institution: Uppsala University, et al.
  7. name: Christine Wegler,et al.
  8. project: Influence of Proteome Profiles and Intracellular Drug Exposure on Differences in CYP Activity in Donor-Matched Human Liver Microsomes and Hepatocytes
  9. project comment: Data from ProteomeXchange, PXD014131. File: Christine_TPA_180223_LysC_H27.mzml. Published as part of Mol Pharm. 2021 Mar 19 (PubMed ). From ProteomeXchange: LC-MS/MS-based label-free proteomics of human liver homogenate, human liver microsomes, and human hepatocytes from 15 matched donors used to compare and understand differences in two major in vitro systems used for drug metabolism studies
17. GPM45100100802
metadata 
peptide 
model 
group 
aaa 
gel
mh
go
2160
  1. BRENDA cell culture: none
  2. BRENDA tissue: BTO:0000759  liver
  3. CELL cell type: none
  4. GO subcellular: none
  5. email: christine.wegler@farmaci.uu.se
  6. institution: Uppsala University, et al.
  7. name: Christine Wegler,et al.
  8. project: Influence of Proteome Profiles and Intracellular Drug Exposure on Differences in CYP Activity in Donor-Matched Human Liver Microsomes and Hepatocytes
  9. project comment: Data from ProteomeXchange, PXD014131. File: Christine_TPA_180223_LysC_H28.mzml. Published as part of Mol Pharm. 2021 Mar 19 (PubMed ). From ProteomeXchange: LC-MS/MS-based label-free proteomics of human liver homogenate, human liver microsomes, and human hepatocytes from 15 matched donors used to compare and understand differences in two major in vitro systems used for drug metabolism studies
18. GPM45100100803
metadata 
peptide 
model 
group 
aaa 
gel
mh
go
2337
  1. BRENDA cell culture: none
  2. BRENDA tissue: BTO:0000759  liver
  3. CELL cell type: none
  4. GO subcellular: none
  5. email: christine.wegler@farmaci.uu.se
  6. institution: Uppsala University, et al.
  7. name: Christine Wegler,et al.
  8. project: Influence of Proteome Profiles and Intracellular Drug Exposure on Differences in CYP Activity in Donor-Matched Human Liver Microsomes and Hepatocytes
  9. project comment: Data from ProteomeXchange, PXD014131. File: Christine_TPA_180223_LysC_H29.mzml. Published as part of Mol Pharm. 2021 Mar 19 (PubMed ). From ProteomeXchange: LC-MS/MS-based label-free proteomics of human liver homogenate, human liver microsomes, and human hepatocytes from 15 matched donors used to compare and understand differences in two major in vitro systems used for drug metabolism studies
19. GPM45100100804
metadata 
peptide 
model 
group 
aaa 
gel
mh
go
2305
  1. BRENDA cell culture: none
  2. BRENDA tissue: BTO:0000759  liver
  3. CELL cell type: none
  4. GO subcellular: none
  5. email: christine.wegler@farmaci.uu.se
  6. institution: Uppsala University, et al.
  7. name: Christine Wegler,et al.
  8. project: Influence of Proteome Profiles and Intracellular Drug Exposure on Differences in CYP Activity in Donor-Matched Human Liver Microsomes and Hepatocytes
  9. project comment: Data from ProteomeXchange, PXD014131. File: Christine_TPA_180223_LysC_H3.mzml. Published as part of Mol Pharm. 2021 Mar 19 (PubMed ). From ProteomeXchange: LC-MS/MS-based label-free proteomics of human liver homogenate, human liver microsomes, and human hepatocytes from 15 matched donors used to compare and understand differences in two major in vitro systems used for drug metabolism studies
20. GPM45100100805
metadata 
peptide 
model 
group 
aaa 
gel
mh
go
2228
  1. BRENDA cell culture: none
  2. BRENDA tissue: BTO:0000759  liver
  3. CELL cell type: none
  4. GO subcellular: none
  5. email: christine.wegler@farmaci.uu.se
  6. institution: Uppsala University, et al.
  7. name: Christine Wegler,et al.
  8. project: Influence of Proteome Profiles and Intracellular Drug Exposure on Differences in CYP Activity in Donor-Matched Human Liver Microsomes and Hepatocytes
  9. project comment: Data from ProteomeXchange, PXD014131. File: Christine_TPA_180223_LysC_H30.mzml. Published as part of Mol Pharm. 2021 Mar 19 (PubMed ). From ProteomeXchange: LC-MS/MS-based label-free proteomics of human liver homogenate, human liver microsomes, and human hepatocytes from 15 matched donors used to compare and understand differences in two major in vitro systems used for drug metabolism studies

Page 1 of 5 | 1 | 2 | 3 | 4 | 5 |
Key word(s): PXD014131
Total protein ids = 224007













dblist_gpmnotes.pl, v. 2017.02.06